Market research
603669.SHG Lionco Pharmaceutical Group Co., Ltd
SHG CNY Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- Not available
- Analyst target
- 31.85
- Dividend yield
- Not available
- Beta
- 0.24
Community
Investor discussion
1 comment
Sign in to join the 603669.SHG discussion.
5 years, 5 months ago
Lionco Pharmaceutical Group Co., Ltd is currently in a long term downtrend where the price is trading 29.2% below its 200 day moving average.
From a valuation standpoint, the stock is 46.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.
Lionco Pharmaceutical Group Co., Ltd's total revenue sank by 20.9% to $296M since the same quarter in the previous year.
Its net income has increased by 84.6% to $76M since the same quarter in the previous year.
Finally, its free cash flow fell by 48.0% to $23M since the same quarter in the previous year.
Based on the above factors, Lionco Pharmaceutical Group Co., Ltd gets an overall score of 2/5.